Amerigen,Ningbo Menovo Pharmaceuticals collaboration agreement

Amerigen, Ningbo Menovo to develop generic pharmaceuticals in US

10:15 AM, 28th August 2014
Amerigen,Ningbo Menovo Pharmaceuticals collaboration agreement

LYNDHURST, US/NINGBO, CHINA: Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co Ltd have entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market. Under the terms of the agreement, Amerigen and Menovo will jointly develop products for Amerigen to commercialize in the United States. Menovo will be responsible for manufacturing API and finished product whereas Amerigen will be responsible for clinical, regulatory and commercial activities in the United States. Amerigen will also provide support and assistance to Menovo in obtaining United States Food and Drug Administration (FDA) approval for their finished dose manufacturing site in Daxie, China.

“This collaboration enables each party to leverage its respective strengths and will broaden Amerigen’s product pipeline. Our first product opportunity leverages formulation work already undertaken by Amerigen at its Suzhou facility and Menovo’s leading position with the corresponding API,” said John Lowry, President and CEO, Amerigen.

 

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


New method to prevent organic food fraud

WASHINGTON DC, US: A growing number of consumers are willing to pay a premium for fruits, vegetables and other foods labelled “organic,” b ...

Read more
DuPont to pay $1.275 million fine for releasing toxic substances in West Virginia

WEST VIRGINIA, US: E.I. duPont de Nemours & Company will pay a $1.275 million fine and take corrective actions at its Belle, West Virginia plant f ...

Read more
Reliance schedules planned turnaround at Hazira manufacturing site, India

MUMBAI, INDIA: Reliance Industries Ltd (RIL) has scheduled a planned turnaround at its Hazira manufacturing site, Surat, India. The cracker unit will ...

Read more
Merck Serono to build pharmaceutical manufacturing facility in China

NANTONG, CHINA: Merck Serono, the biopharmaceutical division of Merck, held the groundbreaking ceremony for its new pharmaceutical manufacturing facil ...

Read more
DSM expands omega-3 production facility in Nova Scotia, Canada

PARSIPPANY, US: DSM Nutritional Products will invest at least $30 million in new capital to upgrade and expand its facilities in Mulgrave, Nova Scotia ...

Read more
Umicore acquires assets of CP Chemicals in Ohio, US

OHIO, US: Umicore announced the acquisition of the business and assets of CP Chemicals in Wickliffe, Ohio, US. CP Chemicals is a refiner and recycler ...

Read more